These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12201054

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
    Hafner L, Walsh L, Rühm W.
    Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
    [Abstract] [Full Text] [Related]

  • 23. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K, Yasuda H, Kawakami H, Tashiro S.
    Radiat Prot Dosimetry; 2018 Aug 01; 180(1-4):346-350. PubMed ID: 29036656
    [Abstract] [Full Text] [Related]

  • 24. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
    Rühm W, Walsh L.
    Radiat Prot Dosimetry; 2007 Aug 01; 126(1-4):423-31. PubMed ID: 17533156
    [Abstract] [Full Text] [Related]

  • 25. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
    Zaider M.
    Health Phys; 1991 Nov 01; 61(5):631-6. PubMed ID: 1752746
    [Abstract] [Full Text] [Related]

  • 26. Relative biological effectiveness of 144 keV neutrons in producing dicentric chromosomes in human lymphocytes compared with 60Co gamma rays under head-to-head conditions.
    Schmid E, Regulla D, Guldbakke S, Schlegel D, Roos M.
    Radiat Res; 2002 Apr 01; 157(4):453-60. PubMed ID: 11893248
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
    Preston DL, Pierce DA.
    Radiat Res; 1988 Jun 01; 114(3):437-66. PubMed ID: 3375435
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M, Schull WJ.
    Radiat Res; 1990 Jan 01; 121(1):3-13. PubMed ID: 2300666
    [Abstract] [Full Text] [Related]

  • 35. Discussion of uncertainties and the impact of different neutron RBEs on all solid cancer radiation incidence risks obtained from the Japanese A-bomb survivor data.
    Hafner L, Walsh L, Rühm W.
    Ann ICRP; 2023 Mar 01; 52(1-2):17-22. PubMed ID: 38143299
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dose and dose rate extrapolation factors for malignant and non-malignant health endpoints after exposure to gamma and neutron radiation.
    Tran V, Little MP.
    Radiat Environ Biophys; 2017 Nov 01; 56(4):299-328. PubMed ID: 28939964
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.